GOG-0277
|
GOG
|
A Phase III Randomized Trial of Gemcitabine (NSC# 613327) Plus Docetaxel (NSC# 628503) Followed by Doxorubicin (NCS# 123127) versus Observation for Uterus-Limited; High Grade Uterine Leiomyosarcoma
|
Adult CIRB - Late Phase Emphasis
|
Completed
|
|
GOG-0281
|
GOG
|
A Randomized Phase II/III Study To Assess The Efficacy of Trametinib (GSK 1120212) In Patients With Recurrent Or Progressive Low-Grade Serous Ovarian Cancer Or Peritoneal Cancer. NCT # NCT02101788
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
GOG-0286B
|
GOG
|
A Randomized Phase II/III Study Of Paclitaxel/Carboplatin/Metformin (NSC#91485) Versus Paclitaxel/Carboplatin/Placebo As Initial Therapy For Measurable Stage III Or IVA; Stage IVB; or Recurrent Endometrial Cancer
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
INT21-05-01
|
CLO-Northwestern University
|
Phase IIB Clinical Trial of the Multitargeted Recombinant Adenovirus 5 (CEA/MUC1/Brachyury) Vaccine (TRI-AD5) and IL-15 Superagonist N-803 in Lynch Syndrome
|
Cancer Prevention and Control CIRB
|
Available to Open
|
|
INT22-09-01
|
CP-CTNet_CLO-University of Wisconsin
|
A Randomized Trial of Apalutamide in Non-Muscle Invasive Bladder Cancer
|
Cancer Prevention and Control CIRB
|
Available to Open
|
|
LungMAP
|
SWOG
|
A Master Protocol to Evaluate Biomarker-Driven Therapies and Immunotherapies in Previously-Treated Non-Small Cell Lung Cancer (Lung-MAP Screening Study)
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
MAY2015-05-01
|
CP-CTNet_CLO-Mayo Clinic
|
Randomized, double-blind, placebo-controlled trial of Meriva® (curcuminoids) as a candidate chemoprevention agent for gastric carcinogenesis
|
Cancer Prevention and Control CIRB
|
Available to Open
|
|
MAY2016-07-01
|
CP-CTNet_CLO-Mayo Clinic
|
Phase II Trial of Weekly Erlotinib Dosing to Reduce Duodenal Polyp Burden Associated with Familial Adenomatous Polyposis
|
Cancer Prevention and Control CIRB
|
Completed
|
|
MAY2016-07-01F
|
CP-CTNet_CLO-Mayo Clinic
|
Review of Post-Study Clinical Endoscopy Reports in Follow Up to MAY2016-07-01 Weekly Erlotinib for Familial Adenomatous Polyposis
|
Cancer Prevention and Control CIRB
|
Completed
|
|
MAY2016-08-01
|
CP-CTNet_CLO-Mayo Clinic
|
A Pilot Study of MUC1 Vaccine in Current and Former Smokers at High Risk for Lung Cancer
|
Cancer Prevention and Control CIRB
|
Available to Open
|
|